Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Ibuprofen to reduce acute inflammation after one-stage non-surgical periodontal therapy

Official title: Efficacy Of Ibuprofen In Reducing Acute Inflammatory Response Following One Stage Non- Surgical Periodontal Therapy (A Randomized Clinical Trial )

Run by University of Baghdad · NCT07459049 · Data updated 2026-11-12

This trial will test whether short-term ibuprofen lowers acute inflammatory markers (hs-CRP, ProCT, IL-6) in adults with generalized periodontitis after one-stage non-surgical periodontal therapy.

More Periodontitis trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorUniversity of Baghdad
Academic / other
Locations1 site (Baghdad)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedJune 2026
Study endsAugust 2026
Registry record updatedMarch 9, 2026
Trial IDNCT07459049 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Systemically healthy adults over 18 with generalized unstable periodontitis, at least 20 teeth, and pocket depths ≥4 mm (smokers allowed) are the intended participants.

Probably not a fit

People with NSAID allergy, current systemic anti-inflammatory or antibiotic use, pregnancy or lactation, severe hepatic/renal/cardiac disease, bleeding disorders, or active high‑risk infections (TB, hepatitis B, HIV) are not likely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants receive baseline clinical exams, demographic data collection, standardized oral hygiene instructions, and baseline blood samples before scaling. One week later full‑mouth root surface debridement is performed in a single session by one periodontist, with the test group given 400 mg ibuprofen one hour before treatment and then three times daily for three days while the control group receives no ibuprofen. Blood biomarkers (hs-CRP, ProCT, IL‑6) are measured at baseline, one hour after therapy, and one week after therapy to compare acute inflammatory responses. Procedure time is recorded and standardized instruments and breaks are used to reduce operator and patient variability.

Why it matters

Potential benefit: If successful, short-term ibuprofen could reduce the immediate systemic inflammatory response after periodontal cleaning and lower short-term inflammation markers.

How similar studies have gone: Previous studies of NSAIDs including ibuprofen have shown some short-term reductions in periodontal inflammation and systemic markers but results have been mixed and not uniformly conclusive.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. systemically healthy patients.
2. having a minimum of 20 teeth.
3. Generalized unstable periodontitis.
4. Pocket depth \[≥ 4 mm\].
5. All included participants should be adults aged more than 18 years .
6. smokers and non smokers

Exclusion Criteria:

1. Allergy or hypersensitivity to Ibuprofen or other NSAIDs.
2. current systemic anti-inflammatory or antibiotic therapy (\<3 months).
3. peptic ulcer disease.
4. recent periodontal therapy (\<3 months).
5. Asthma.
6. Renal impairment .
7. Hepatic impairment.
8. Severe cardiac disease (heart failure, hypertension (.
9. Bleeding disorders (e.g., hemophilia) or patients taking anticoagulants .
10. Any participant who had known or suspected high risk for tuberculosis, hepatitis B or HIV infections.
11. pregnant or lactating females.
12. those being unable to provide written informed consent.

Where it's running

  • College of Dentistry, University of Baghdad
    Baghdad, Iraq
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.